CAS: 56961-10-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SARS-CoV-2-IN-13 REF: TM-T60919CAS: 56961-10-5 | 98.15% | 36.00 €~1,607.00 € | Fri 31 Jan 25 |
SARS-CoV-2-IN-13
CAS:56961-10-5
SARS-CoV-2-IN-13, a stable niclosamide analogue, enhances oral bioavailability and inhibits SARS-CoV-2 (IC50: 0.057 μM).
Formula:
C13H8Cl2N2O4
Purity:
98.15%
Color and Shape:
Liquid
Molecular weight:
327.12
Ref: TM-T60919
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 112.00 € | ||
| 25mg | 218.00 € | ||
| 50mg | 324.00 € | ||
| 100mg | 464.00 € | ||
| 200mg | 629.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Friday 31 Jan 2025
